Literature DB >> 28915437

Temporal characterization of the non-structural Adenovirus type 2 proteome and phosphoproteome using high-resolving mass spectrometry.

Malin Källsten1, Arina Gromova1, Hongxing Zhao2, Alberto Valdés1, Anne Konzer1, Ulf Pettersson2, Sara Bergström Lind3.   

Abstract

The proteome and phosphoproteome of non-structural proteins of Adenovirus type 2 (Ad2) were time resolved using a developed mass spectrometry approach. These proteins are expressed by the viral genome and important for the infection process, but not part of the virus particle. We unambiguously confirm the existence of 95% of the viral proteins predicted to be encoded by the viral genome. Most non-structural proteins peaked in expression at late time post infection. We identified 27 non-redundant sites of phosphorylation on seven different non-structural proteins. The most heavily phosphorylated protein was the DNA binding protein (DBP) with 15 different sites. The phosphorylation occupancy rate could be calculated and monitored with time post infection for 15 phosphorylated sites on various proteins. In the DBP, phosphorylations with time-dependent relation were observed. The findings show the complexity of the Ad2 non-structural proteins and opens up a discussion for potential new drug targets.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenovirus type 2; Mass spectrometry; Non-structural proteins; Phosphorylation; Protein expression; Time series

Mesh:

Substances:

Year:  2017        PMID: 28915437     DOI: 10.1016/j.virol.2017.08.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Temporal dynamics of adenovirus 5 gene expression in normal human cells.

Authors:  Leandro Crisostomo; Andrea Michelle Soriano; Megan Mendez; Drayson Graves; Peter Pelka
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

2.  Time-resolved proteomics of adenovirus infected cells.

Authors:  Alberto Valdés; Hongxing Zhao; Ulf Pettersson; Sara Bergström Lind
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.